Olympus medical systems corp.(omsc) received a literature titled "real-life indications and outcome of electrocautery-enhanced lumen-apposing metal stents in a tertiary center".Literature summary.Purpose: electrocautery-enhanced lumen-apposing stents (ec-lams) were originally designed for the drainage of the gallbladder, bile duct, and pancreas pseudocysts.Throughout the years, several off-label indications were established.This study aims to evaluate the indication, safety, efficacy, and outcome of all lams implanted in a single tertiary referral center.Methods: from (b)(6) 2022, all patients undergoing lams placement in a single tertiary center were included.We present a detailed analysis of indications, success rates, and complications based on a retrospective analysis of our prospectively maintained database.Results: a total of 86 stents were placed in 77 patients between (b)(6) 2022.Indications were walled-off pancreatic necrosis (25.6%), bile duct obstructions (16.3%), acute cholecystitis (15.1%), pancreas pseudocysts (15.1%), postoperative collections (10.5%), postoperative pancreatic fistulas (9.3%), and gastro-gastrostomy/jejunostomy (8.1%) to enable to perform an endoscopic retrograde cholangiopancreatography in patients with gastric bypass.Technical success was 97.7% (84 out of 86).A total of 10 (11.7%) adverse events were observed.In 3 patients (3.5%), severe complications occurred, which required acute surgery; one displacement was closed through clips.In 7 patients (8.2%), bleedings occurred during necrosectomy or from mucosal erosions at the stent side, respectively, that were treated with endoclips.Conclusions: (electrocautery-enhanced lumen-apposing stents (ec-lamss) are safe and show a high technical success rate in all indications.In everyday clinical practice, the main indications are hepato-pancreato-biliary, and therefore an hepato-pan-creato-biliary-surgical department should have ec-lams in their armamentarium.Type of adverse events/number of patient.Event1: bleeding during necrosectomy (1).Event2: bleeding after implantation of the stent (1).Event3: bleeding by mucosal erosion from the stent (5).Event4: perforation (2).Event5: dislocation (1).Event6: acute cholecistitis (1).Event7: acute abdomen (1).Event8: deaths (2).Per literature the 2 patients deaths within the first month after stent placement were unrelated to the procedure.This literature article requires 6 reports.The related patient identifiers are as follows: 1) patient identifier # (b)(6), single use retrieval basket fg-v422pr, sn-unk.2) patient identifier # (b)(6), single use retrieval basket, fg-v422pr, sn-unk.3) patient identifier # (b)(6), evis exera ii ultrasound gastrovideoscope, gf-uct180, sn-unk.4) patient identifier # (b)(6), evis exera ii ultrasound gastrovideoscope, gf-uct180, sn-unk.5) patient identifier # (b)(6), ultrasonic gastrovideoscope, gf-uct140-al5, sn-unk (this report).6) patient identifier # (b)(6), ultrasonic gastrovideoscope, gf-uct140-al5, sn-unk.There is no report of any olympus device malfunction in any procedure described in this study.
|